Using TargetScan, miR-22 was found to target multiple mRNAs implicated in HD pathogenesis; among the targets is HDAC4, which has been shown to reverse histone acetylation and plays a neuroprotective effect in animal and cellular models of HD (Harding and Tong, 2018). This evidence concerns the gene HDAC4 and Huntington disease.